Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 321.0
(0.0%)
JPY 321.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - JPY | -100.0% |
| 2022 | 529 Thousand JPY | -66.71% |
| 2021 | 1.58 Million JPY | -40.02% |
| 2020 | 2.64 Million JPY | -28.58% |
| 2019 | 3.7 Million JPY | 73.81% |
| 2018 | 2.13 Million JPY | -95.29% |
| 2017 | 45.33 Million JPY | -78.26% |
| 2016 | 208.53 Million JPY | -43.9% |
| 2015 | 371.73 Million JPY | -45.97% |
| 2014 | 688 Million JPY | 218.52% |
| 2013 | 216 Million JPY | -80.4% |
| 2012 | 1.1 Billion JPY | -17.39% |
| 2011 | 1.33 Billion JPY | 8.46% |
| 2010 | 1.23 Billion JPY | -13.74% |
| 2009 | 1.42 Billion JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| 2007 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - JPY | 0.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 Q4 | - JPY | 0.0% |
| 2023 Q1 | - JPY | -100.0% |
| 2023 FY | - JPY | -100.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2022 Q1 | - JPY | -100.0% |
| 2022 FY | 529 Thousand JPY | -66.71% |
| 2022 Q4 | 529 Thousand JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2021 Q2 | - JPY | 0.0% |
| 2021 Q4 | 1.58 Million JPY | 0.0% |
| 2021 Q3 | - JPY | 0.0% |
| 2021 FY | 1.58 Million JPY | -40.02% |
| 2021 Q1 | - JPY | -100.0% |
| 2020 Q4 | 2.64 Million JPY | 0.0% |
| 2020 Q1 | - JPY | -100.0% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 FY | 2.64 Million JPY | -28.58% |
| 2019 Q4 | 3.7 Million JPY | 0.0% |
| 2019 FY | 3.7 Million JPY | 73.81% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2019 Q1 | - JPY | -100.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 FY | 2.13 Million JPY | -95.29% |
| 2018 Q4 | 2.13 Million JPY | 0.0% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | -100.0% |
| 2017 Q4 | 45.33 Million JPY | -43.33% |
| 2017 FY | 45.33 Million JPY | -78.26% |
| 2017 Q3 | 80 Million JPY | -33.33% |
| 2017 Q2 | 120 Million JPY | -25.0% |
| 2017 Q1 | 160 Million JPY | -23.27% |
| 2016 Q1 | 320 Million JPY | -13.92% |
| 2016 FY | 208.53 Million JPY | -43.9% |
| 2016 Q4 | 208.53 Million JPY | -13.11% |
| 2016 Q3 | 240 Million JPY | -14.29% |
| 2016 Q2 | 280 Million JPY | -12.5% |
| 2015 Q2 | 440 Million JPY | -30.82% |
| 2015 FY | 371.73 Million JPY | -45.97% |
| 2015 Q4 | 371.73 Million JPY | -7.07% |
| 2015 Q1 | 636 Million JPY | -7.56% |
| 2015 Q3 | 400 Million JPY | -9.09% |
| 2014 FY | 688 Million JPY | 218.52% |
| 2014 Q2 | 792 Million JPY | -6.16% |
| 2014 Q4 | 688 Million JPY | -7.03% |
| 2014 Q3 | 740 Million JPY | -6.57% |
| 2014 Q1 | 844 Million JPY | 290.74% |
| 2013 Q2 | 434 Million JPY | -5.03% |
| 2013 Q3 | 228 Million JPY | -47.47% |
| 2013 Q4 | 216 Million JPY | -5.26% |
| 2013 FY | 216 Million JPY | -80.4% |
| 2013 Q1 | 457 Million JPY | -58.53% |
| 2012 Q3 | 1.16 Billion JPY | -4.98% |
| 2012 Q4 | 1.1 Billion JPY | -5.25% |
| 2012 Q2 | 1.22 Billion JPY | -4.75% |
| 2012 FY | 1.1 Billion JPY | -17.39% |
| 2012 Q1 | 1.28 Billion JPY | -3.67% |
| 2011 Q2 | 1.43 Billion JPY | 21.25% |
| 2011 FY | 1.33 Billion JPY | 8.46% |
| 2011 Q3 | 1.38 Billion JPY | -3.42% |
| 2011 Q1 | 1.18 Billion JPY | -3.98% |
| 2011 Q4 | 1.33 Billion JPY | -3.54% |
| 2010 Q4 | 1.23 Billion JPY | -3.83% |
| 2010 FY | 1.23 Billion JPY | -13.74% |
| 2010 Q1 | 1.37 Billion JPY | -3.44% |
| 2010 Q2 | 1.32 Billion JPY | -3.56% |
| 2010 Q3 | 1.27 Billion JPY | -3.69% |
| 2009 Q4 | 1.42 Billion JPY | -3.32% |
| 2009 Q3 | 1.47 Billion JPY | 27.82% |
| 2009 Q2 | 1.15 Billion JPY | 0.0% |
| 2009 FY | 1.42 Billion JPY | 0.0% |
| 2008 Q3 | - JPY | 0.0% |
| 2008 Q4 | - JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |